Abstract:BACKGROUND: Generally, the main sources of stem cells are embryonic stem cells and bone marrow stem cells, but there are some limitations of the two kinds of sources, and researchers strive to find a new type of stem cells in order to overcome the potential for teratoma, the lack of sample sources, ethics controversies and so on. OBJECTIVE: To isolate, culture and identify menstrual blood-derived mesenchymal stem cells (MMCs). METHODS: MMCs were separated by Ficoll density gradient centrifugation. Cell morphology and growth characteristics were observed. Flow cytometry analysis was used to identify expression of CD29, CD44, CD34, CD45, HLA-ABC and HLA-DR surface markers in MMCs. Immunocytochemical method was utilized to detect nestin-positive cells in MMCs. RESULTS AND CONCLUSION: MMCs were successfully separated from menstrual blood by Ficoll density gradient centrifugation. About 2 weeks later, primary cells reached 80% to 90% confluence; cells were spiral-shaped, mesh and radial. After passage to a stable growth, cells could be seen as the leading fiber-like cell morphology. Results from flow cytometry showed that MMCs were highly positive for CD29, positive for CD44, low positive for HLA-ABC, but negative for CD34, CD45 and HLA-DR. Staining showed nestin expression of antigen in MMCs was about (10. 35±0. 51)%. Results have suggested that MMCs express MSCs markers, and only have low immunogenicity. MMCs express nestin antigen and provide some theoretical basis for MMCs in the nervous system application.

Isolation, culture and identification of menstrual blood-derived mesenchymal stem cells